Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

REBYOTA™ Prospective Registry

ClinicalTrials.gov ID: NCT05835219

Public ClinicalTrials.gov record NCT05835219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study

Study identification

NCT ID
NCT05835219
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
145 participants

Conditions and interventions

Interventions

  • REBYOTA™ Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2023
Primary completion
Aug 28, 2025
Completion
Aug 28, 2025
Last update posted
Jan 27, 2026

2023 – 2025

United States locations

U.S. sites
42
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
Ferring Investigational Site Chandler Arizona 85224
Ferring Investigational Site Chula Vista California 91910
Ferring Investigational Site Murrieta California 92563
Ferring Investigational Site Oceanside California 92054
Ferring Investigational Site Sacramento California 95816
Ferring Investigational Site Hamden Connecticut 06518
Ferring Investigational Site Gainesville Florida 32610
Ferring Investigational Site Orlando Florida 32806
Ferring Investigational Site Port Orange Florida 32127
Ferring Investigational Site Tampa Florida 33614
Ferring Investigational Site Zephyrhills Florida 33542
Ferrin Investigational Site Atlanta Georgia 30322
Ferring Investigational Site La Grange Georgia 30240
Ferring Investigational Site Savannah Georgia 31405
Ferring Investigational Site Burr Ridge Illinois 60527
Ferring Investigational Site Maywood Illinois 60153
Ferring Investigational Site Iowa City Iowa 52242
Ferring Investigational Site Wichita Kansas 67211
Ferring Investigational Site Jefferson Louisiana 70121
Ferring Investigational Site Boston Massachusetts 02115
Ferring Investigational Site Worcester Massachusetts 01608
Ferring Investigational Site Detroit Michigan 48201
Ferring Investigational Site Detroit Michigan 48202
Ferring Investigational Site Farmington Hills Michigan 48336
Ferring Investigational Site Omaha Nebraska 68198
Ferring Investigational Site Teaneck New Jersey 07666
Ferring Investigational Site New York New York 10016
Ferring Investigational Site New York New York 10021
Ferring Investigational Site New York New York 10279
Ferring Investigational Site Rochester New York 14618
Ferring Investigational Site Stony Brook New York 11794
Ferring Investigational Site Fargo North Dakota 58122
Ferring Investigational Site Cincinnati Ohio 45267
Ferring Investigational Site Middleburg Heights Ohio 44130
Ferring Investigational Site DuBois Pennsylvania 15801
Ferring Investigational Site Pittsburgh Pennsylvania 15237
Ferring Investigational Site Charleston South Carolina 29425
Ferring Investigational Site Knoxville Tennessee 37909
Ferring Investigational Site Dallas Texas 75246
Ferring Investigational Site Houston Texas 77030
Ferring Investigational Site West Jordan Utah 84088
Ferring Investigational Site Charlottesville Virginia 22903

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05835219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05835219 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →